News Release - Callout Image

 

News Room

This page is designed to provide you with quick and easy access to key information about King Pharmaceuticals. Here you will find an archive of King news releases, information about our company and leaders and how to reach us.
If you cannot find what you’re looking for, please contact our Corporate Affairs department at 908-429-8350.

02/04/2008 King Pharmaceuticals To Present At Merrill Lynch Conference
01/14/2008 King Pharmaceuticals Reports FDA Approval Of Revised Labeling Regarding Purity Of THROMBIN-JMI®
01/08/2008 King Pharmaceuticals To Present At JPMorgan Healthcare Conference
12/06/2007 Remoxy™ Meets Primary Endpoint in Pivotal Phase III Study
12/03/2007 King Pharmaceuticals Reports Petition For Rehearing and Rehearing En Banc Denied
11/13/2007 King Pharmaceuticals To Present At Credit Suisse Healthcare Conference
11/08/2007 King Pharmaceuticals Reports Third-Quarter 2007 Financial Results PDF File - 11-08-2007_3Q_2007_Earnings_Release_Comp.pdf
11/06/2007 King Pharmaceuticals Announces Webcast To Review Financial Results for The Third Quarter Ended September 30, 2007 And Provide a Strategic Update
11/01/2007 King Pharmaceuticals Files Citizen Petition With FDA Asserting ZymoGenetics Has Not Submitted Adequate Data For Approval Of Its Recombinant Thrombin Product
10/31/2007 King Pharmaceuticals And Acura Pharmaceuticals Enter Agreement To Develop And Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion® (Abuse-Deterrent) Technology

 

pdf icon

Documents marked with this icon are presented in Portable Document Format (PDF) to retain the original format. To view or print this document, you must use the Adobe® Acrobat® Reader®. Acrobat® Reader® is free and available directly from Adobe’s Web site with full installation instructions. You can either view and print this document or save it to your computer’s hard drive to open later. Your method may vary depending on your operating system and browser type.

Get Acrobat

“Adobe” and “the Adobe logo” are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.